Superinfections in patients treated with teicoplanin as anti SARSCoV2 AGENT

European Journal of Clinical Investigation, 2021 - iris.uniroma1.it
We read with interest the paper by Giacobbe et al. estimating a cumulative risk of developing
at least one bloodstream infection (BSI) episode (largely due to Gram-positive pathogens) of …
被引用次数：14 相关文章
[PDF] researchgate.net

[PDF][PDF] Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent

Eur J Clin Invest, 2021 - researchgate.net
Dear Editor, We read with interest the paper by Giacobbe et al estimating a cumulative risk
of developing at least one bloodstream infection (BSI) episode (largely due to Gram-positive …

Superinfections in patients treated with Teicoplanin as anti‐SARS‐CoV‐2 agent

G Ceccarelli, F Alessandri, A Oliva… - European Journal of …, 2021 - ncbi.nlm.nih.gov
Superinfections in patients treated with Teicoplanin as anti‐SARS‐CoV‐2 agent - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Superinfections in patients treated with Teicoplanin as anti‐SARS‐CoV‐2 agent.

G Ceccarelli, F Alessandri, A Oliva… - … Journal of Clinical …, 2021 - search.ebscohost.com
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent We read with
interest the paper by Giacobbe et al estimating a cumulative risk of developing at least one …
[PDF] core.ac.uk

[PDF][PDF] Superinfections in patients treated with Teicoplanin as anti-SARSCoV2 agent

G Ceccarelli, F Alessandri, A Oliva, S Dell'Isola… - core.ac.uk
We read with interest the paper by Giacobbe et al. estimating a cumulative risk of developing
at least one bloodstream infection (BSI) episode (largely due to Gram-positive pathogens) of …
[PDF] uniroma1.it

[PDF][PDF] Superinfections in patients treated with Teicoplanin as anti-SARSCoV2 agent

G Ceccarelli, F Alessandri, A Oliva, S Dell'Isola… - iris.uniroma1.it
We read with interest the paper by Giacobbe et al. estimating a cumulative risk of developing
at least one bloodstream infection (BSI) episode (largely due to Gram-positive pathogens) of …

Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent

G Ceccarelli, F Alessandri, A Oliva… - … journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent Superinfections
in patients treated with Teicoplanin as anti-SARS-CoV-2 agent Eur J Clin Invest. 2021 …

[引用][C] Superinfections in patients treated with Teicoplanin as anti‐SARS‐CoV‐2 agent

G Ceccarelli, F Alessandri, A Oliva… - European Journal of …, 2021 - Wiley Online Library
Superinfections in patients treated with Teicoplanin as antiâ•’SARSâ•’CoVâ•’2 agent Page 1 Eur
J Clin Invest. 2021;51:e13418. | 1 of 3 https://doi.org/10.1111/eci.13418 …

Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent.

G Ceccarelli, F Alessandri, A Oliva… - European Journal of …, 2020 - europepmc.org
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent.

G Ceccarelli, F Alessandri, A Oliva… - European Journal of …, 2020 - europepmc.org
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …